Zhou J - Search Results

1

MRGBP promotes colorectal cancer metastasis via DKK1/Wnt/β-catenin and NF-kB/p65 pathways mediated EMT.

Long X, Hu Y, Duan S, Liu X, Huang W, Liu X, Xu Q, Song W, Zhou J. Long X, et al. Among authors: zhou j. Exp Cell Res. 2022 Dec 1;421(1):113375. doi: 10.1016/j.yexcr.2022.113375. Epub 2022 Oct 5. Exp Cell Res. 2022. PMID: 36208716

2

Long non-coding RNA FEZF1-AS1 facilitates cell proliferation and migration in colorectal carcinoma.

Chen N, Guo D, Xu Q, Yang M, Wang D, Peng M, Ding Y, Wang S, Zhou J. Chen N, et al. Among authors: zhou j. Oncotarget. 2016 Mar 8;7(10):11271-83. doi: 10.18632/oncotarget.7168. Oncotarget. 2016. PMID: 26848625 Free PMC article.

3

MIER3 suppresses colorectal cancer progression by down-regulating Sp1, inhibiting epithelial-mesenchymal transition.

Peng M, Hu Y, Song W, Duan S, Xu Q, Ding Y, Geng J, Zhou J. Peng M, et al. Among authors: zhou j. Sci Rep. 2017 Sep 8;7(1):11000. doi: 10.1038/s41598-017-11374-y. Sci Rep. 2017. PMID: 28887525 Free PMC article.

4

IMPDH2 promotes colorectal cancer progression through activation of the PI3K/AKT/mTOR and PI3K/AKT/FOXO1 signaling pathways.

Duan S, Huang W, Liu X, Liu X, Chen N, Xu Q, Hu Y, Song W, Zhou J. Duan S, et al. Among authors: zhou j. J Exp Clin Cancer Res. 2018 Dec 5;37(1):304. doi: 10.1186/s13046-018-0980-3. J Exp Clin Cancer Res. 2018. PMID: 30518405 Free PMC article.

5

[Corrigendum] Knockdown of lncRNA HNF1A-AS1 inhibits oncogenic phenotypes in colorectal carcinoma.

Zhu W, Zhuang P, Song W, Duan S, Xu Q, Peng M, Zhou J. Zhu W, et al. Among authors: zhou j. Mol Med Rep. 2019 Aug;20(2):2039-2040. doi: 10.3892/mmr.2019.10373. Epub 2019 Jun 11. Mol Med Rep. 2019. PMID: 31257539 Free PMC article.

6

POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway.

Xu Q, Chen J, Peng M, Duan S, Hu Y, Guo D, Geng J, Zhou J. Xu Q, et al. Among authors: zhou j. Exp Cell Res. 2020 May 1;390(1):111933. doi: 10.1016/j.yexcr.2020.111933. Epub 2020 Mar 3. Exp Cell Res. 2020. PMID: 32142855

7

CSRP2 suppresses colorectal cancer progression via p130Cas/Rac1 axis-meditated ERK, PAK, and HIPPO signaling pathways.

Chen L, Long X, Duan S, Liu X, Chen J, Lan J, Liu X, Huang W, Geng J, Zhou J. Chen L, et al. Among authors: zhou j. Theranostics. 2020 Sep 2;10(24):11063-11079. doi: 10.7150/thno.45674. eCollection 2020. Theranostics. 2020. PMID: 33042270 Free PMC article.

8

MIER3 induces epithelial-mesenchymal transition and promotes breast cancer cell aggressiveness via forming a co-repressor complex with HDAC1/HDAC2/Snail.

Huang W, Chen J, Liu X, Liu X, Duan S, Chen L, Liu X, Lan J, Zou Y, Guo D, Zhou J. Huang W, et al. Among authors: zhou j. Exp Cell Res. 2021 Sep 1;406(1):112722. doi: 10.1016/j.yexcr.2021.112722. Epub 2021 Jul 6. Exp Cell Res. 2021. PMID: 34242623

9

Corrigendum to "POTEE promotes colorectal carcinoma progression via activating the Rac1/Cdc42 pathway" [Exp. Cell Res. 390 (1) (1 May 2020) 111933].

Xu Q, Chen J, Peng M, Duan S, Hu Y, Guo D, Geng J, Zhou J. Xu Q, et al. Among authors: zhou j. Exp Cell Res. 2021 Oct 15;407(2):112836. doi: 10.1016/j.yexcr.2021.112836. Epub 2021 Sep 24. Exp Cell Res. 2021. PMID: 34565520 No abstract available.

10

Down-regulated expression of SATB2 is associated with metastasis and poor prognosis in colorectal cancer.

Wang S, Zhou J, Wang XY, Hao JM, Chen JZ, Zhang XM, Jin H, Liu L, Zhang YF, Liu J, Ding YQ, Li JM. Wang S, et al. Among authors: zhou j. J Pathol. 2009 Sep;219(1):114-22. doi: 10.1002/path.2575. J Pathol. 2009. PMID: 19557828

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

55,201 results

Search Page

Filters